Physician profile
Randy Dean
NPI 1831216258
$1,164.94
in general payments reported to CMS, 2019-2025
18 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $167 · 2021: $171 · 2022: $11.82 · 2024: $13.70 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $246.78 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $201.38 | 2019-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $171.65 | 2021-2025 | Caplyta |
| Sunovion Pharmaceuticals INC. | $99.81 | 2019-2020 | |
| Shire North American Group INC | $74.55 | 2019 | |
| Neurocrine Biosciences, INC. | $58.59 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.73 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $44.12 | 2019 | |
| Allergan, INC. | $36.92 | 2019 | |
| Tris Pharma INC | $35.45 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $31.00 | 2019-2020 | |
| Noven Therapeutics, LLC | $23.98 | 2025 | Xelstrym |
| Bausch Health US, LLC | $15.58 | 2019 | |
| Adlon Therapeutics L.P. | $15.36 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.23 | 2025 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $13.70 | 2024 | Lybalvi |
| Teva Pharmaceuticals USA, INC. | $13.29 | 2019 | |
| Livanova USA, INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.